Judiciary · 4 sources ⚠ Andekha — no coverage found on the Left in our feed sample
'Why only cancer drugs?': SC questions Centre on trade margin cap, seeks wider price regulation
Coverage by lean
0% Left75% Centre25% Lean Right
Left 0
No coverage found on this side
Centre 3
Right 1
One headline per side, the first Trikon holds. Every outlet is listed below.
Left · 0
No coverage found on this side.
Centre · 3
Mint · Centre
'Why only cancer drugs?': SC questions Centre on trade margin cap, seeks wider price regulation
◈ HT Media, K. K. Birla Group (Shobhana Bhartia)
Free Press Journal · Centre
Centre Caps Cancer Drug Trade Margins At 30 Per Cent, Supreme Court Questions High Prices Of Other Medicines
◈ Indian National Press (Bombay), Karnani family
The Hans India · Centre
Centre to cap trade margins on cancer drugs, SC calls for broader price review
◈ Hyderabad Media House Ltd; Kapil Group (K. Vaman Rao)
Right · 1
Business Standard · Lean Right
Govt submits proposal to cap trade margins on anti-cancer drugs at 30%
◈ Business Standard Pvt Ltd (Kotak family, Uday Kotak)
Verify with IFCN fact-checkers →NewsCheckerIFCN ↗Fact CrescendoIFCN ↗Alt NewsIFCN ↗BOOMIFCN ↗Google Fact Check ↗